Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Geisslinger, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 127 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Brautigam, L; Vetter, G; Tegeder, I; Heinkele, G; Geisslinger, G
      Determination of celecoxib in human plasma and rat microdialysis samples by liquid chromatography tandem mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    2. Guhring, H; Tegeder, I; Lotsch, J; Pahl, A; Werner, U; Reeh, PW; Rehse, K; Brune, K; Geisslinger, G
      Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia

      INFLAMMATION RESEARCH
    3. Schmidt, H; Geisslinger, G
      Selective cyclooxygenase-2 inhibitor. Pharmacology and state of knowledge following commercial availability

      SCHMERZ
    4. Tegeder, I; Niederberger, E; Israr, E; Guhring, H; Brune, K; Euchenhofer, C; Grosch, S; Geisslinger, G
      Inhibition of NF-KB and AP-1 activation by R- and S-flurbiprofen

      FASEB JOURNAL
    5. Tegeder, I; Pfeilschifter, J; Geisslinger, G
      Cyclooxygenase-independent actions of cyclooxygenase inhibitors

      FASEB JOURNAL
    6. Grosch, S; Tegeder, I; Niederberger, E; Brautigam, L; Geisslinger, G
      COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib

      FASEB JOURNAL
    7. Tegeder, I; Niederberger, E; Israr, E; Guhring, H; Brune, K; Euchenhofer, C; Grosch, S; Geisslinger, G
      Inhibition of NF-kappa B and AP-1 activation by R- and S-flurbiprofen

      FASEB JOURNAL
    8. Tegeder, I; Lotsch, J; Kinzig-Schippers, M; Sorgel, F; Kelm, GR; Meller, ST; Geisslinger, G
      Comparison of tissue concentrations after intramuscular and topical administration of ketoprofen

      PHARMACEUTICAL RESEARCH
    9. Lotsch, J; Geisslinger, G
      Morphine-6-glucuronide - An analgesic of the future?

      CLINICAL PHARMACOKINETICS
    10. Grosch, S; Niederberger, E; Lotsch, J; Skarke, C; Geisslinger, G
      A rapid screening method for a single nucleotide polymorphism (SNP) in thehuman MOR gene

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    11. Lotsch, J; Muth-Selbach, U; Tegeder, I; Brune, K; Geisslinger, G
      Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    12. Vetter, G; Geisslinger, G; Tegeder, I
      Release of glutamate, nitric oxide and prostaglandin E-2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation

      PAIN
    13. Lotsch, J; Darimont, J; Skarke, C; Zimmermann, M; Hummel, T; Geisslinger, G
      Effects of the opioid remifentanil on olfactory function in healthy volunteers

      LIFE SCIENCES
    14. Tegeder, I; Niederberger, E; Vetter, G; Brautigam, L; Geisslinger, G
      Effects of selective COX-1 and-2 inhibition on formalin-evoked nociceptivebehaviour and prostaglandin E-2 release in the spinal cord

      JOURNAL OF NEUROCHEMISTRY
    15. Franzen, R; Pautz, A; Brautigam, L; Geisslinger, G; Pfeilschifter, J; Huwiler, A
      Interleukin-1 beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    16. Ihmsen, H; Geisslinger, G; Schuttler, J
      Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    17. Brugger, R; Reichel, C; Alia, BG; Brune, K; Yamamoto, T; Tegeder, I; Geisslinger, G
      Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics (vol 61, pg 651, 2001)

      BIOCHEMICAL PHARMACOLOGY
    18. Lotsch, J; Skarke, C; Schmidt, H; Grosch, S; Geisslinger, G
      The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers

      ANESTHESIOLOGY
    19. Lotsch, J; Kettenmann, B; Renner, B; Drover, D; Brune, K; Geisslinger, G; Kobal, G
      Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: Relation to pharmacodynamics in an experimental pain model

      PHARMACEUTICAL RESEARCH
    20. Grosser, K; Oelkers, R; Hummel, T; Geisslinger, G; Brune, K; Kobal, G; Lotsch, J
      Olfactory and trigeminal event-related potentials in migraine

      CEPHALALGIA
    21. Maihofner, C; Tegeder, I; Euchenhofer, C; Dewitt, D; Brune, K; Bang, R; Neuhuber, W; Geisslinger, G
      Localization and regulation of cyclo-oxygenase-1 and-2 and neuronal nitricoxide synthase in mouse spinal cord

      NEUROSCIENCE
    22. Maihofner, C; Euchenhofer, C; Tegeder, I; Beck, KF; Pfeilschifter, J; Geisslinger, G
      Regulation and immunhistochemical localization of nitric oxide synthases and soluble guanylyl cyclase in mouse spinal cord following nociceptive stimulation

      NEUROSCIENCE LETTERS
    23. Dormann, H; Muth-Selbach, U; Krebs, S; Criegee-Rieck, M; Tegeder, I; Schneider, HT; Hahn, EG; Levy, M; Brune, K; Geisslinger, G
      Incidence and costs of adverse drug reactions during hospitalisation - Computerised monitoring versus stimulated spontaneous reporting

      DRUG SAFETY
    24. Lotsch, J; Tegeder, I; Angst, MS; Geisslinger, G
      Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotin knockout and in wildtype mice in the hotplate test

      LIFE SCIENCES
    25. Tegeder, I; Neupert, W; Guhring, H; Geisslinger, G
      Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    26. Geisslinger, G; Muth-Selbach, U; Coste, O; Vetter, G; Schrodter, A; Schaible, HG; Brune, K; Tegeder, I
      Inhibition of noxious stimulus-induced spinal prostaglandin E-2 release byflurbiprofen enantiomers: A microdialysis study

      JOURNAL OF NEUROCHEMISTRY
    27. Albrecht, S; Fechner, J; Geisslinger, G; Maass, AB; Upadhyaya, B; Moecke, HP; Haigh, C; Schuttler, J
      Postoperative pain control following remifentanil-based anaesthesia for major abdominal surgery

      ANAESTHESIA
    28. Tegeder, I; Geisslinger, G; Lotsch, J
      Therapy with opioids in liver or renal failure

      SCHMERZ
    29. Erb, K; Brugger, R; Williams, K; Geisslinger, G
      Stereoselective disposition of tiaprofenic acid enantiomers in rats

      CHIRALITY
    30. Tegeder, I; Lotsch, J; Geisslinger, G
      Pharmacokinetics of opioids in liver disease

      CLINICAL PHARMACOKINETICS
    31. Tegeder, I; Levy, M; Muth-Selbach, U; Oelkers, R; Neumann, F; Dormann, H; Azaz-Livshits, T; Criegee-Rieck, M; Schneider, HT; Hahn, EG; Brune, K; Geisslinger, G
      Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    32. Levy, M; Azaz-Livshits, T; Sadan, B; Shalit, M; Geisslinger, G; Brune, K
      Computerized surveillance of adverse drug reactions in hospital: Implementation

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    33. Albrecht, S; Ihmsen, H; Hering, W; Geisslinger, G; Dingemanse, J; Schwilden, H; Schuttler, J
      The effect of age on the pharmacokinetics and pharmacodynamics of midazolam

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    34. Tegeder, I; Lotsch, J; Krebs, S; Muth-Selbach, U; Brune, K; Geisslinger, G
      Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    35. Tegeder, I; Muth-Selbach, U; Lotsch, J; Rusing, G; Oelkers, R; Brune, K; Meller, S; Kelm, GR; Sorgel, F; Geisslinger, G
      Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    36. Tegeder, I; Neumann, F; Bremer, F; Brune, K; Lotsch, J; Geisslinger, G
      Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    37. Oelkers, R; Grosser, K; Lang, E; Geisslinger, G; Kobal, G; Brune, K; Lotsch, J
      Visual evoked potentials in migraine patients: alterations depend on pattern spatial frequency

      BRAIN
    38. Muth-Selbach, US; Tegeder, I; Brune, K; Geisslinger, G
      Acetaminophen inhibits spinal prostaglandin E-2 release after peripheral noxious stimulation

      ANESTHESIOLOGY
    39. Lotsch, J; Weiss, M; Ahne, G; Kobal, G; Geisslinger, G
      Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers

      ANESTHESIOLOGY
    40. Koppert, W; Likar, R; Geisslinger, G; Zeck, S; Schmelz, M; Sittl, R
      Peripheral antihyperalgesic effect of morphine to heat, but not mechanical, stimulation in healthy volunteers after ultraviolet-B irradiation

      ANESTHESIA AND ANALGESIA
    41. Beiche, F; Brune, K; Geisslinger, G; Goppelt-Struebe, M
      Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis

      INFLAMMATION RESEARCH
    42. Lotsch, J; Kobal, G; Geisslinger, G
      No contribution of morphine-6-glucuronide to clinical morphine effects after short-term administration

      CLINICAL NEUROPHARMACOLOGY
    43. LEVY M; CARACO Y; GEISSLINGER G
      DRUG ACETYLATION IN LIVER-DISEASE

      Clinical pharmacokinetics
    44. AZAZLIVSHITS T; LEVY M; SADAN B; SHALIT M; GEISSLINGER G; BRUNE K
      COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG-REACTIONS IN-HOSPITAL - PILOT-STUDY

      British journal of clinical pharmacology
    45. EUCHENHOFER C; MAIHOFNER C; BRUNE K; TEGEDER I; GEISSLINGER G
      DIFFERENTIAL EFFECT OF SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITOR NS-398 AND DICLOFENAC ON FORMALIN-INDUCED NOCICEPTION IN THE RAT

      Neuroscience letters
    46. DORMANN H; BERG P; MEYER M; GEISSLINGER G; SCHUPPAN D; BRUNE K; HAHN EG; SCHNEIDER HT
      HEMATOLOGICAL TOXICITY OF INTERFERON-ALPHA IN HEPATITIS-C A KINETIC-STUDY

      Hepatology
    47. GUEHRING H; PAHL A; REEH P; BRUNE K; GEISSLINGER G
      ANTINOCICEPTIVE AND ANTIINFLAMMATORY EFFECTS OF COX AND NOS INHIBITORS - ROLE OF COX-2 AND INOS IN NOCICEPTIVE PROCESSING IN SPINAL-CORD AND IN INFLAMED PAW OF RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    48. BRUGGER R; REICHEL C; BRUNE K; GEISSLINGER G
      NEW INSIGHTS INTO THE PHYSIOLOGICAL-ROLE OF 2-ARYLPROPIONYL-COA EPIMERASE

      Naunyn-Schmiedeberg's archives of pharmacology
    49. MAIHOFNER C; BANG R; NEUHUBER W; BELCHE F; EUCHENHOFER C; GEISSLINGER G
      LOCALIZATION OF CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 AND NO-SYNTHASE-I IN THE SPINAL-CORD OF MICE

      Naunyn-Schmiedeberg's archives of pharmacology
    50. GUEHRING H; PAHL A; REEH P; BRUNE K; GEISSLINGER G
      ROLE OF CYCLOOXYGENASE (COX)-2 ON THERMAL HYPERALGESIA EVOKED BY ZYMOSAN INJECTION IN THE RAT

      Naunyn-Schmiedeberg's archives of pharmacology
    51. HINZ B; GEISSLINGER G; BRUNE K; PAHL A
      EFFECT OF IBUPROFEN ON THE EXPRESSION OF CYCLOOXYGENASE-2 AND INDUCIBLE NITRIC-OXIDE SYNTHASE IN MURINE RAW-264.7 MACROPHAGES

      Naunyn-Schmiedeberg's archives of pharmacology
    52. BREMER F; LOTSCH J; BRUNE K; SCHUTTLER J; GEISSLINGER G; TEGEDER I
      COMPARISON OF PHARMACOKINETICS OF MEROPENEM AND IMIPENEM IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE UNDERGOING CONTINUOUS VENOVENOUS HEMOFILTRATION

      Naunyn-Schmiedeberg's archives of pharmacology
    53. CRIEGEERIECK M; LOTSCH J; TEGEDER I; GUHRING H; GEISSLINGER G
      TEACHING CLINICAL-PHARMACOLOGY WITH ADVANCED MULTIMEDIA AND INTERNET TECHNOLOGIES

      Naunyn-Schmiedeberg's archives of pharmacology
    54. LOTSCH J; WEISS M; AHNE G; BRUNE K; KOBAL G; GEISSLINGER G
      PHARMACOKINETIC MODELING OF M6G FORMATION AFTER ORAL AND INTRAVENOUS ADMINISTRATION OF MORPHINE IN HEALTHY-VOLUNTEERS

      Naunyn-Schmiedeberg's archives of pharmacology
    55. TEGEDER I; MUTHSELBACH U; OELKERS R; LOTSCH J; BRUNE K; SORGEL F; GEISSLINGER G
      APPLICATION OF HUMAN MICRODIALYSIS FOR THE EVALUATION OF TISSUE IBUPROFEN CONCENTRATIONS AFTER PERORAL AND TOPICAL ADMINISTRATION

      Naunyn-Schmiedeberg's archives of pharmacology
    56. MUTHSELBACH U; TEGEDER I; KREBS S; NEUPERT W; BRUNE K; GEISSLINGER G
      EFFECTS OF MELOXICAM AND DICLOFENAC ON HUMAN THROMBOXANE BIOSYNTHESIS

      Naunyn-Schmiedeberg's archives of pharmacology
    57. SCHEUERER S; WILLIAMS KM; BRUGGER R; MCLACHLAN AJ; BRUNE K; DAY RO; GEISSLINGER G
      EFFECT OF CLOFIBRATE ON THE CHIRAL DISPOSITION OF IBUPROFEN IN RATS

      The Journal of pharmacology and experimental therapeutics
    58. SCHEUERER S; HALL SD; WILLIAMS KM; GEISSLINGER G
      EFFECT OF CLOFIBRATE ON THE CHIRAL INVERSION OF IBUPROFEN IN HEALTHY-VOLUNTEERS

      Clinical pharmacology and therapeutics
    59. LEVY M; BRUNE K; ZYLBERKATZ E; COHEN O; CARACO Y; GEISSLINGER G
      CEREBROSPINAL-FLUID PROSTAGLANDINS AFTER SYSTEMIC DIPYRONE INTAKE

      Clinical pharmacology and therapeutics
    60. LOTSCH J; WEISS M; KOBAL G; GEISSLINGER G
      PHARMACOKINETICS OF MORPHINE-6-GLUCURONIDE AND ITS FORMATION FROM MORPHINE AFTER INTRAVENOUS ADMINISTRATION

      Clinical pharmacology and therapeutics
    61. LOTSCH J; GROSSER K; OELKERS R; BRUNE K; LANG E; GEISSLINGER G; KOBAL G
      NASAL CHEMOSENSITIVITY IN HEADACHE - INDICATIONS FOR THE NEURONAL THEORY OF PATHOGENESIS OF MIGRAINE

      Clinical pharmacology and therapeutics
    62. GEISSLINGER G; NEUPERT W; BRUGGER R
      STEREOSELECTIVE EFFECTS OF IBUPROFEN AND ITS COENZYME-A THIOESTERS ONHUMAN PROSTAGLANDIN ENDOPEROXIDE SYNTHASES (PGHSS)

      Clinical pharmacology and therapeutics
    63. SCHAIBLE HG; NEUGEBAUER V; GEISSLINGER G; BECK U
      THE EFFECTS OF S-FLURBIPROFEN AND R-FLURBIPROFEN ON THE INFLAMMATION-EVOKED INTRASPINAL RELEASE OF IMMUNOREACTIVE SUBSTANCE-P - A STUDY WITH ANTIBODY MICROPROBES

      Brain research
    64. ERB K; LIEBEL JT; TEGEDER I; ZEILHOFER HU; BRUNE K; GEISSLINGER G
      SPINALLY DELIVERED NOCICEPTIN ORPHANIN FQ REDUCES FLINCHING BEHAVIOR IN THE RAT FORMALIN TEST/

      NeuroReport
    65. SURI A; ESTES KS; GEISSLINGER G; DERENDORF H
      PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS FOR ANALGESICS

      International journal of clinical pharmacology and therapeutics
    66. OELKERS R; NEUPERT W; WILLIAMS KM; BRUNE K; GEISSLINGER G
      DISPOSITION AND EFFECTS OF FLURBIPROFEN ENANTIOMERS IN HUMAN SERUM AND BLISTER FLUID

      British journal of clinical pharmacology
    67. GEISSLINGER G; BRUNE K; KOBAL G; LOTSCH J
      INTRAVENOUS MORPHINE-6-GLUCURONIDE (M6G) IS DEVOID OF ANALGESIC ACTIVITY IN MAN

      Pain
    68. TEGEDER I; SCHUMACHER A; JOHN S; GEIGER H; GEISSLINGER G; BANG H; BRUNE K
      ELEVATED SERUM CYCLOPHILIN LEVELS IN PATIENTS WITH SEVERE SEPSIS

      Journal of clinical immunology
    69. TEGEDER I; BREMER F; OELKERS R; SCHOBEL H; SCHUTTLER J; BRUNE K; GEISSLINGER G
      PHARMACOKINETICS OF IMIPENEM-CILASTATIN IN CRITICALLY ILL PATIENTS UNDERGOING CONTINUOUS VENOVENOUS HEMOFILTRATION

      Antimicrobial agents and chemotherapy
    70. HUMMEL T; CRAMER O; MOHAMMADIAN P; GEISSLINGER G; PAULI E; KOBAL G
      COMPARISON OF THE ANTINOCICEPTION PRODUCED BY 2 ORAL FORMULATIONS OF IBUPROFEN - IBUPROFEN EFFERVESCENT VS IBUPROFEN TABLETS

      European Journal of Clinical Pharmacology
    71. GEISSLINGER G
      TREATMENT OF PAIN WITH CYCLOOXYGENASE-INHIBITORS - CYCLOOXYGENASE-2 AS A NEW TARGET

      Naunyn-Schmiedeberg's archives of pharmacology
    72. SCHEUERER S; BRUGGER R; WILLIAMS KM; BRUNE K; GEISSLINGER G
      EFFECT OF CLOFIBRATE ON THE STEREOSELECTIVE UPTAKE OF IBUPROFEN INTO VARIOUS TISSUES

      Naunyn-Schmiedeberg's archives of pharmacology
    73. BRUGGER R; REICHEL C; ALIA BG; BRUNE K; YAMAMOTO T; GEISSLINGER G
      ROLE OF LONG-CHAIN ACYL-COA SYNTHETASE IN THE METABOLISM OF IBUPROFENAND OTHER FATTY-ACID LIKE XENOBIOTICS

      Naunyn-Schmiedeberg's archives of pharmacology
    74. BEICHE F; BRUNE K; GEISSLINGER G; GOPPELTSTRUBE M
      CYCLOOXYGENASE ISOFORM EXPRESSION IN THE RAT SPINAL-CORD FOLLOWING PERIPHERAL INFLAMMATION

      Naunyn-Schmiedeberg's archives of pharmacology
    75. ERB K; LIEBEL J; ZEILHOFER HU; BRUNE K; GEISSLINGER G
      IS NOCICEPTIN ANTINOCICEPTIVE

      Naunyn-Schmiedeberg's archives of pharmacology
    76. OELKERS R; GROSSER K; LOTSCH J; LANG E; BRUNE K; GEISSLINGER G; KOBAL G
      PATTERN-REVERSAL VISUAL-EVOKED POTENTIALS AT DIFFERENT SPATIAL-FREQUENCIES IN MIGRAINE

      Naunyn-Schmiedeberg's archives of pharmacology
    77. LOTSCH J; KOBAL G; STOCKMANN A; BRUNE K; GEISSLINGER G
      PHARMACOKINETICS OF MORPHINE AND ITS GLUCURONIDES IN HEALTHY-VOLUNTEERS

      Naunyn-Schmiedeberg's archives of pharmacology
    78. NEUPERT W; BRUGGER R; BRUNE K; GEISSLINGER G
      STEREOSELECTIVE INHIBITION OF CYCLOOXYGENASE-1 (COX-1) AND COX-2 BY IBUPROFENOYL-COA-THIOESTERS AND IBUPROFEN ENANTIOMERS

      Naunyn-Schmiedeberg's archives of pharmacology
    79. TEGEDER I; BREMER F; OELKERS R; SCHUTTLER J; BRUNE K; GEISSLINGER G
      THERAPEUTIC DRUG-MONITORING OF IMIPENEM DURING CONTINUOUS VENOVENOUS HEMOFILTRATION

      Naunyn-Schmiedeberg's archives of pharmacology
    80. REICHEL C; BRUGGER R; BANG H; GEISSLINGER G; BRUNE K
      MOLECULAR-CLONING AND EXPRESSION OF A 2-ARYLPROPIONYL-COENZYME-A EPIMERASE - A KEY ENZYME IN THE INVERSION METABOLISM OF IBUPROFEN

      Molecular pharmacology
    81. SCHEUREN N; NEUPERT W; IONAC M; NEUHUBER W; BRUNE K; GEISSLINGER G
      PERIPHERAL NOXIOUS-STIMULATION RELEASES SPINAL PGE2 DURING THE FIRST-PHASE IN THE FORMALIN ASSAY OF THE RAT

      Life sciences
    82. IONAC M; LASKAY T; LABAHN D; GEISSLINGER G; SOLBACH W
      IMPROVED TECHNIQUE FOR CANNULATION OF THE MURINE THORACIC-DUCT - A VALUABLE TOOL FOR THE DISSECTION OF IMMUNE-RESPONSES

      Journal of immunological methods
    83. WILLIAMS KM; TURNER J; GEISSLINGER G; DAY RO
      THE SUCTION BLISTER AS AN IN-VIVO MODEL OF INFLAMMATION - INTERBLISTER VARIABILITY AND PRELIMINARY STUDIES OF THE DISPOSITION OF METHOTREXATE

      Clinical pharmacology and therapeutics
    84. NEUPERT W; BRUGGER R; EUCHENHOFER C; BRUNE K; GEISSLINGER G
      EFFECTS OF IBUPROFEN ENANTIOMERS AND ITS COENZYME-A THIOESTERS ON HUMAN PROSTAGLANDIN ENDOPEROXIDE SYNTHASES

      British Journal of Pharmacology
    85. LOTSCH J; KOBAL G; STOCKMANN A; BRUNE K; GEISSLINGER G
      LACK OF ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDE AFTER SHORT-TERMINTRAVENOUS ADMINISTRATION IN HEALTHY-VOLUNTEERS

      Anesthesiology
    86. GEISSLINGER G; MENZEL S; BRUNE K
      STEREOSPECIFIC DETERMINATION OF TIAPROFENIC ACID IN PLASMA - PROBLEMSWITH DRUG DEGRADATION

      Journal of chromatography B. Biomedical applications
    87. GEISSLINGER G; BOCKER R; LEVY M
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF DIPYRONE METABOLITES TO STUDY THEIR FORMATION IN HUMAN LIVER-MICROSOMES

      Pharmaceutical research
    88. GEISSLINGER G; PESKAR BA; PALLAPIES D; SITTL R; LEVY M; BRUNE K
      THE EFFECTS ON PLATELET-AGGREGATION AND PROSTANOID BIOSYNTHESIS OF 2 PARENTERAL ANALGESICS - KETOROLAC TROMETHAMINE AND DIPYRONE

      Thrombosis and haemostasis
    89. DAY RO; WILLIAMS KM; GEISSLINGER G
      NAPROXEN CONCENTRATIONS IN PLASMA AND SYNOVIAL-FLUID AND EFFECTS ON PROSTANOID CONCENTRATIONS - REPLY

      Journal of rheumatology
    90. GEISSLINGER G; SCHAIBLE HG
      NEW INSIGHTS INTO THE SITE AND MODE OF ANTINOCICEPTIVE ACTION OF FLURBIPROFEN ENANTIOMERS

      Journal of clinical pharmacology
    91. OELKERS R; IONAC M; ERB K; BRUNE K; GEISSLINGER G
      TRANSFER OF DIFFERENT NONSTEROIDAL ANTIINFLAMMATORY DRUGS VIA THE LYMPHATIC-SYSTEM IN THE RAT

      Drug metabolism and disposition
    92. NEUPERT W; OELKERS R; BRUNE K; GEISSLINGER G
      A NEW RELIABLE CHEMILUMINESCENCE IMMUNOASSAY (CLIA) FOR PROSTAGLANDINE(2) USING ENHANCED LUMINOL AS SUBSTRATE

      Prostaglandins
    93. CRAMER O; HUMMEL T; MOHAMMADIAN P; LOTSCH J; GEISSLINGER G; KOBAL G
      COMPARISON OF THE ANTINOCICEPTION PRODUCED BY 2 ORAL FORMULATIONS OF IBUPROFEN - IBUPROFEN EFFERVESCENT VS IBUPROFEN TABLETS

      Naunyn-Schmiedeberg's archives of pharmacology
    94. BEICHE F; SCHEUERER S; BRUNE K; GEISSLINGER G; GOPPELTSTRUEBE M
      UP-REGULATION OF CYCLOOXYGENASE-2 MESSENGER-RNA IN THE RAT SPINAL-CORD FOLLOWING PERIPHERAL INFLAMMATION

      FEBS letters
    95. LOTSCH J; STOCKMANN A; KOBAL G; BRUNE K; WAIBEL R; SCHMIDT N; GEISSLINGER G
      PHARMACOKINETICS OF MORPHINE AND ITS GLUCURONIDES AFTER INTRAVENOUS-INFUSION OF MORPHINE AND MORPHINE-6-GLUCURONIDE IN HEALTHY-VOLUNTEERS

      Clinical pharmacology and therapeutics
    96. LOTSCH J; STOCKMANN A; GEISSLINGER G; KOBAL G
      LACK OF ANALGESIC EFFECTS OF MORPHINE-6-GLUCURONIDE AFTER IV-ADMINISTRATION IN MAN

      Clinical pharmacology and therapeutics
    97. GEISSLINGER G; OELKERS R; NEUPERT W; WILLIAMS KM; BRUNE K
      EFFECT OF FLURBIPROFEN (FLU) ENANTIOMERS ON PROSTAGLANDIN E(2) (PGE(2)) AND SUBSTANCE-P (SP) LEVELS IN HUMAN SUCTION BLISTER

      Clinical pharmacology and therapeutics
    98. BRUGGER R; ALIA BG; REICHEL C; WAIBEL R; MENZEL S; BRUNE K; GEISSLINGER G
      ISOLATION AND CHARACTERIZATION OF RAT-LIVER MICROSOMAL R-IBUPROFENOYL-COA SYNTHETASE

      Biochemical pharmacology
    99. HERING WJ; IHMSEN H; LANGER H; UHRLAU C; DINKEL M; GEISSLINGER G; SCHUTTLER J
      PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE NEW STEROID HYPNOTIC ELTANOLONE IN HEALTHY-VOLUNTEERS

      Anesthesiology
    100. DAY RO; GEISSLINGER G; PAULL P; WILLIAMS KM
      THE EFFECT OF TENOXICAM ON TOLBUTAMIDE PHARMACOKINETICS AND GLUCOSE-CONCENTRATIONS IN HEALTHY-VOLUNTEERS

      International journal of clinical pharmacology and therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 10:19:28